MedPath

Study to assess usefulness of placing catheter in the spinal column for pain relief in transgender patients undergoing sex change operation ( from man to women)

Completed
Conditions
Transsexualism,
Registration Number
CTRI/2019/01/016900
Lead Sponsor
Mahatma Gandhi Medical College and Research Institute
Brief Summary

Perineal and anorectal surgeries can cause severe postoperative pain and discomfort due to its dense nerve supply and sympathetic reflexes. Good postoperative analgesia is important for early rehabilitation and prevent chronic perineal or post- surgical pain. In gender re-assignment surgery, there is extensive surgical manipulation and reconstruction of the genitals and perineum leading to increased pain and discomfort.  The commonly practiced lumbar epidural block can produce inadequate analgesia and undue motor blockade, which can prevent early ambulation and rehabilitation of these patients. Hence, we aim to analyse postoperative analgesia via ultrasound guided caudal catheter for gender re-assignment surgeries in transgender patients.

our aim is toassess the effectively of caudal analgesia via caudal epidural catheter forpost-operative analgesia in gender re-assignment surgeries in Transgenderpatients

Patient will be positioned in left lateralknee chest position. After strictaseptic precaution, Sonosite Xporte (Sonosite, Bothwell, WA) ultrasound systemwith multi-beam (compound array) capability and with high frequency lineararray transducer (HFL 50, 15-10 MHz) will be used to perform the caudal block.The USG probe will be placed on the sacrum and scanned downward till the sacralhiatus is identified (Frog eye appearance). 18G touhy needle will be introducedin an out-plane approach towards the sacral hiatus and once the needle crossesthe sacro-coccegyeal ligament (pop up), the skin epidural space distance willbe noted and epidural catheter will be threaded till 5cms in epidural space. Distanceof caudal space from skin, no of attempts to needle insertion, total durationfor block performance will be documented. A test dose of 3 mL of 2 % lignocainewith 1 in 200000 adrenaline will be administered to rule out intravascular andintra-thecal placement of catheter.

Spinal anaesthesia will be administered with 3mL of 0.5 % hyperbaric bupivacaine through 25 G Quincke’s needle. Patient willbe placed in supine position and sensory level assessed. After adequate levelof anaesthesia is achieved, surgery will commence.Patientwill be continuously monitored and hemodynamic parameters recorded every 5minstill the end of surgery.

Caudal catheter will be activated whensensory anaesthesia level descends to L1 dermatome with 10 cc of 0.2%ropivacaine with 1mcg /kg clonidine and the subsequent dose will be administerednext day morning.  static and dynamic pain score, total local anaesthetic  and adjuvant consumption, ambulation and patient satisfaction score.

The study will be terminated after the time frame of 6 months or a miminum of 30 patients are recruited

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • 1.Female Transgender 2.Male to Female transition surgeries 3.Age 18 to 60 years 4.
  • ASA I – II.
Exclusion Criteria

1.Patient refusal 2.Spinal deformities 3.Patients allergic to local anaesthetics 4.Patients with coagulopathy 5.Patients with neurological deficits and neuromuscular diseases 6.Patients with infection at the site of injection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Static and Dynamic Visual Numeric Rating Scale for pain1, 2,4,6,8,12,24,36 and 72 hours in the postoperative period
Secondary Outcome Measures
NameTimeMethod
1.Total dose of local anaesthetics and additives2.Total dose of rescue systemic analgesia

Trial Locations

Locations (1)

Mahatma Gandhi Medical College and Research Institute

🇮🇳

Pondicherry, PONDICHERRY, India

Mahatma Gandhi Medical College and Research Institute
🇮🇳Pondicherry, PONDICHERRY, India
Dr Annie John
Principal investigator
9655035791
dr.anniej@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.